AstraZeneca Pulls Plug On Covid-19 Vaccine Amid Report On Rare Side Effects, Cites 'Commercial Reasons' For The Decision
AstraZeneca Admits Its Covishield Vaccine Can Cause Rare Side Effects: Here's What They Are
Explained: The Debate Over If, When And How Of Covid-19 Vaccine Booster Shots In India
Why I Think mRNA Vaccines Are Not The Best Choice For Booster Doses
Oxford-Based Experts Among Others Share Their Views On Whether Vaccines Will Protect Against Omicron
Booster Doses? Vaccination For Children? SUTRA Team Answers Your Questions
AstraZeneca Enters The Crowded Field Of Covid-19 Medicines With Its Antibody Cocktail
UK Updates List Of Vaccines To Accept Covishield; Still No Clarity On Acceptance Of CoWIN Certificate
Vaccines Are Helping The World To Combat Covid-19 But This Pandemic Battle Needs Better Strategy
AstraZeneca Says New Data Demonstrates 92 Per Cent Vaccine Effectiveness Against Delta Variant
AstraZeneca And Sputnik V Makers Give Positive Response Over Telangana Govt's Global Tender For COVID Vaccine Supply
S Jaishankar To Visit US Next Week To Seal Deals On Covid-19 Vaccine Supplies
50 Lakh Covishield Doses Earmarked For Export To UK To Now Be Used For Vaccinating 18-44 Age Group In India
Sweden Planning To Donate One Million Doses of AstraZeneca COVID-19 Vaccines To India
WHO Approves Moderna Covid-19 Vaccine For Emergency Use, Fifth Jab To Receive Validation From Global Health Body
Raw Materials Are Not Needed For Manufacturing Of Covishield, But For Covovax, Serum Institute To US Govt
US Likely To Send 20 Million Doses Of Covid-19 Vaccine To India From Its AstraZeneca Order: Report
Vaccinomics 1.0: There Is No Free Lunch Even When It Comes To Life-Savers
How Bharat Biotech Plans To Overcome Production Challenges Due To Export Restrictions On Raw Materials By US
India’s Covid Critics Are Back: They Are Right For Now, But Will Be Proved Wrong Again
US Stops Production Of AstraZeneca's COVID-19 Vaccines At A Baltimore-Based Vaccine Maker's Facility
Canadian Committee On Immunization Recommends Pause On AstraZeneca Covid-19 Vaccine For People Younger Than 55 Years
WHO Recommends Continuing Use Of AstraZeneca COVID-19 Jab, Says Benefits Of Vaccine Outweigh Its Risks
Germany, France And Italy Temporarily Halt Use Of AstraZeneca’s COVID-19 Vaccine Over Blood Clot Concerns
Netherlands Joins The List Of Countries To Have Suspend Use Of AstraZeneca Vaccine Over Side Effect Concerns
AstraZeneca COVID-19 Vaccine Side Effects: India To Conduct Deeper Review After Suspension Of Use By Some Nations
Indian Drug Regulator DCGI Approves Covid-19 Vaccines of AstraZeneca And Bharat Biotech
Biggest Pharma Sector Deal Of 2020: AstraZeneca To Buy US-Based Biotech Major Alexion For $39 Billion
Serum Institute To Accord First Priority To India For AstraZeneca/Oxford Vaccine’s Delivery: Adar Poonawalla
Covid-19: AstraZeneca, Oxford University Vaccine Shows Up To 90% Effectiveness In Late-Stage Trials
Serum Institute Completes At-Risk Manufacturing Of 40 Million Doses Of Oxford-AstraZeneca's Covishield Vaccine
Oxford-AstraZeneca Covid-19 Vaccine Likely To Be Ready For Use As Early As December: Serum Institute CEO
Oxford University's Covid-19 Vaccine To Be Rolled Out In UK Within Three Months: Report
Serum Institute Gets DGCI Approval To Resume Clinical Trials Of Oxford-AstraZeneca's COVID-19 Vaccine In India
After Adverse Reaction In United Kingdom, Serum Institute Halts Indian Trials Of Oxford-AstraZeneca Covid-19 Vaccine
Trials Of Front-Runner Oxford-AstraZeneca COVID-19 Vaccine Paused After Adverse Reaction In A Participant: Report
With Three Drugmakers In Final Stages Of Testing, US Preparing For Distribution Of Covid-19 Vaccine By 1 November
Pune’s Serum Institute Gets DCGI Nod For Clinical Trials Of Oxford University-Astra Zeneca Covid-19 Vaccine In India
Five Sites In India Ready For Phase 3 Human Trials Of Oxford-AstraZeneca Covid-19 Vaccine
Serum Institute To Start Human Trials For Oxford Vaccine In India From August
